/PRNewswire/ Gender reassignment surgery market insights - Vendors: 15+, Including Andrew Ives., Boston Children s Hospital, Boston Medical Center, British.
/PRNewswire/ The "Gender Reassignment Surgery Market by Gender Transition and Geography - Forecast and Analysis 2021-2025" report by Technavio expects the.
/PRNewswire/ The gender reassignment surgery market size is set to increase by USD 209.07 million, accelerating at over 8% from 2020 to 2025, according to.
Filed to:aducanumab
alzheimers diseasebiogenclinical trialfederal assistance in the united statesfood and drug administrationhealth medical pharmahealthcare reform in the united statesjanet woodcockkaiser family foundationkatie porterlife sciencesmedicaidmedicarepresidency of lyndon b johnsonsam gandythe centers for medicare and medicaid services
Photo: Matthew Simmons, Getty Images
Parts of the medical world are continuing to rebel against Aduhelm, the controversial treatment developed by Biogen and recently approved for Alzheimer’s disease by the U.S. Food and Drug Administration. This week, two major medical centres in the U.S. said that they would not treat their patients with the drug.
The Cleveland Clinic, as first reported by the New York Times yesterday, assembled a formal panel of experts to review the evidence behind aducanumab, the active ingredient of Aduhelm, before coming to their decision.
After the Keira Bell verdict
An English ruling on transgender teens could have global repercussions
Worries grow over treatments that can leave children sterile
I
N 2018 ANDREA DAVIDSON’S 12-year-old daughter, Meghan, announced she was “definitely a boy”. Ms Davidson says her child was never a tomboy but the family doctor congratulated her and asked what pronouns she had chosen, before writing a referral to the British Columbia Children’s Hospital (
BCCH). “We thought we were going to see a psychologist, but it was a nurse and a social worker,” says Ms Davidson (both her and her daughter’s names have been changed). “Within ten minutes they had offered our child Lupron” a puberty-blocking drug. “They brought up the drug directly with our child, in front of us, without discussing it with us privately first.” There was no mention of other mental-health issues, which are known to increase the likelihood of gender dysphoria, the feeling that you are in the wrong